Valuation: Zoetis Inc.

Market Cap 33.55B 30.34B 28B 25.35B 47.83B 3,154B 49.27B 336B 134B 1,686B 126B 123B 5,367B P/E 2026 *
14.5x
P/E 2027 * 13.7x
Enterprise Value 40.2B 36.35B 33.56B 30.37B 57.32B 3,779B 59.03B 403B 160B 2,020B 151B 148B 6,431B EV / Sales 2026 *
4.33x
EV / Sales 2027 * 4.26x
Free-Float
80.99%
Yield 2026 *
2.57%
Yield 2027 * 2.72%
1 day+0.30%
1 week+1.19%
Current month+4.23%
1 month+9.83%
3 months+12.99%
6 months+7.99%
Current year-33.96%
1 week 78.63
Extreme 78.63
83.84
1 month 74.25
Extreme 74.25
89.29
Current year 68.77
Extreme 68.77
132.49
1 year 68.77
Extreme 68.77
132.49
3 years 68.77
Extreme 68.77
201.92
5 years 68.77
Extreme 68.77
249.27
10 years 48.24
Extreme 48.235
249.27
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 53 2026-08-16
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 Free

Director

6 0.0000%
10/9/26 Free

Executive Vice President

321 0.0001% -
10/9/26 Free

Executive/Senior Manager

278 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+1.19%-31.47%-50.78% 33.55B
+0.76%+6.27%+42.49%+136.69% 1,280B
+1.72%+4.92%+46.99%+93.54% 675B
+0.58%+3.04%+27.34%+114.22% 521B
+1.14%+3.78%+39.98%+70.26% 386B
+1.29%+1.35%+62.85%+45.34% 363B
+1.11%+0.07%+28.19%+58.61% 301B
+0.24%-0.80%+3.05%+35.93% 286B
+0.64%+2.47%+40.26%+76.85% 253B
+0.45%+1.93%+38.42%+127.96% 211B
Average +0.84%-1.21%+29.81%+70.86% 431B
Weighted average by Cap. +0.96%+0.14%+38.33%+96.03%

Financials

2026 *2027 *
Net sales 9.29B 8.4B 7.75B 7.02B 13.24B 873B 13.64B 93.05B 36.98B 467B 34.86B 34.11B 1,486B 9.34B 8.44B 7.79B 7.06B 13.31B 878B 13.71B 93.56B 37.18B 469B 35.05B 34.3B 1,494B
Net income 2.4B 2.17B 2.01B 1.82B 3.43B 226B 3.53B 24.08B 9.57B 121B 9.02B 8.83B 384B 2.41B 2.18B 2.01B 1.82B 3.44B 227B 3.54B 24.16B 9.6B 121B 9.05B 8.86B 386B
Net Debt 6.65B 6.01B 5.55B 5.02B 9.48B 625B 9.77B 66.63B 26.48B 334B 24.96B 24.43B 1,064B 6.25B 5.65B 5.22B 4.72B 8.92B 588B 9.18B 62.65B 24.9B 314B 23.47B 22.97B 1,000B
Projected Income Statement - Annual - Zoetis Inc.
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-11-12 US$83.15 +0.70% 889,023
26-11-11 US$82.57 +0.13% 4,450,294
26-11-10 US$82.46 +0.17% 4,894,311
26-11-09 US$82.32 +3.68% 6,205,132
26-11-06 US$79.40 -3.30% 6,024,575
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Zoetis Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
82.57USD
Average target price
89.69USD
Spread / Average Target
+8.63%